Overview
William “Bill” Gaede was profiled for his 2016 Delaware federal court win that affirmed the patent validity of client Amgen’s new anti-cholesterol drugs. “It’s always a challenge to figure out how to take a complex scientific topic and communicate it to the jury in a relatable manner,” Mr. Gaede explained, noting that in this case “our IP litigators had the unique ability to digest and explain technical and scientific terminology in an approachable way” for the judge and jury.
